Put company on watchlist
HBM Healthcare Investments AG
ISIN: CH0012627250
WKN: 984345
About
Company Snapshot
New: Activate notification
Be informed about new publications
New: AI Factsheet

Coming soon: Summary of the company message by AI/p>

HBM Healthcare Investments AG · ISIN: CH0012627250 · Newswire (adhoc)
Country: Schweiz · Primary market: Switzerland · EQS NID: 2110152
01 April 2025 17:49PM

HBM Healthcare Investments expects to report a net profit of CHF 19 million for the 2024/2025 financial year


HBM Healthcare Investments AG / Key word(s): Annual Results
HBM Healthcare Investments expects to report a net profit of CHF 19 million for the 2024/2025 financial year

01-Apr-2025 / 17:49 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


In a market environment that remains difficult for the biotech sector, HBM Healthcare Investments closed the 2024/2025 financial year with a net profit of CHF 19 million as of 31 March. Net asset value per share (NAV) rose by 1.5 percent to CHF 244.41. The share price fell slightly by 2.6 percent.

Some of the relevant healthcare sector indices recorded significant losses during the reporting year. Measured in Swiss francs, the Nasdaq Biotech Index and the S&P Biotech ETF lost 5.2 percent and 16.0 percent, respectively. The broader MSCI World Healthcare Index lost 2.5 percent.

HBM Healthcare Investments' solid performance relative to the market was due in particular to value-enhancing transactions in the private equity portfolio (the acquisitions of two clinical development stage companies Yellow Jersey Threpeutics (by Johnson & Johnson) and Dren Bio (by Sanofi), and the IPO of SAI Life Sciences in India). In addition, the positive performance of the two largest investments in the portfolio, the private company Swixx Biopharma and the listed company Cathay Biotech, contributed to the good result.

Negative currency effects reduced the performance in Swiss francs by around 1.8 percent.

The results presented here are provisional and unaudited based on the current status of the financial statements. The final result will be published with the 2024/2025 Annual Report on 15 May.

Contact
For further information, please contact Dr Andreas Wicki on +41 41 710 75 77, or at andreas.wicki@hbmhealthcare.com.



End of Inside Information
Language: English
Company: HBM Healthcare Investments AG
Bundesplatz 1
6300 Zug
Switzerland
Phone: +41438887171
Fax: +41438887172
E-mail: info@hbmhealthcare.com
Internet: https://www.hbmhealthcare.com
ISIN: CH0012627250
Valor: 1262725
Listed: SIX Swiss Exchange
EQS News ID: 2110152

 
End of Announcement EQS News Service

2110152  01-Apr-2025 CET/CEST

smart.AD

Trading Solutions for Professionals

  • 25 kinds of clusters
  • 26 world exchanges
  • 14 different charts
  • 58 necessary for analysis indicators
  • 50+ customized templates for charts


Get your free Demo today

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Wednesday, 02.04.2025, Calendar Week 14, 92nd day of the year, 273 days remaining until EoY.